UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 276

Sortiert nach

Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists

Cardiovascular diabetology, 2014-10, Vol.13 (1), p.142-142, Article 142

2014

Volltextzugriff (PDF)

GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data

Cardiovascular diabetology, 2018-12, Vol.17 (1), p.157-19, Article 157

2018

Volltextzugriff (PDF)

Effect of aluminum accumulation on bone and cardiovascular risk in the current era

PloS one, 2023-04, Vol.18 (4), p.e0284123-e0284123

2023

Volltextzugriff (PDF)

Very low HDL levels: clinical assessment and management

Archives of Endocrinology and Metabolism, 2023-01, Vol.67 (1), p.3-18

2023

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study

Hypertension research, 2022-02, Vol.45 (2), p.364-368

2022

Volltextzugriff (PDF)

High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1290

2024

Volltextzugriff (PDF)

Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction

Arteriosclerosis, thrombosis, and vascular biology, 2019-08, Vol.39 (8), p.1550

2019

Volltextzugriff (PDF)

Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk

European heart journal, 2022-05, Vol.43 (19), p.1861

Sposito, Andrei C

2022

Volltextzugriff (PDF)

Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease

Annals of medicine (Helsinki), 2024-12, Vol.56 (1), p.2343890-2343890

2024

Volltextzugriff (PDF)

Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk

European heart journal, 2022-05, Vol.43 (19), p.1861-1863

Sposito, Andrei C

2022

Volltextzugriff (PDF)

Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use

Arteriosclerosis, thrombosis, and vascular biology, 2021-01, Vol.41 (1), p.153

2021

Volltextzugriff (PDF)

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

Cardiovascular diabetology, 2021-03, Vol.20 (1), p.74-74, Article 74

2021

Volltextzugriff (PDF)

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial

International journal of molecular sciences, 2024-04, Vol.25 (7), p.4108

2024

Volltextzugriff (PDF)

Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians

Journal of lipid research, 2018-04, Vol.59 (4), p.714-721

2018

Volltextzugriff (PDF)

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications

Journal of clinical medicine, 2021-05, Vol.10 (11), p.2233

2021

Volltextzugriff (PDF)

Relationship between office isolated systolic or diastolic hypertension and white-coat hypertension across the age spectrum: a home blood pressure study

Journal of hypertension, 2020-04, Vol.38 (4), p.663

2020

Volltextzugriff (PDF)

Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy

Scientific reports, 2021-08, Vol.11 (1), p.17132-17132, Article 17132

2021

Volltextzugriff (PDF)

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus

Metabolites, 2021-11, Vol.11 (12), p.807

2021

Volltextzugriff (PDF)

The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: a meta-analysis

Diabetology and metabolic syndrome, 2024-04, Vol.16 (1), p.92-92, Article 92

2024

Volltextzugriff (PDF)

Reference values of office central blood pressure, pulse wave velocity, and augmentation index recorded by means of the Mobil-O-Graph PWA monitor

Hypertension research, 2020-11, Vol.43 (11), p.1239-1248

2020

Volltextzugriff (PDF)

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial

Cardiovascular diabetology, 2022-08, Vol.21 (1), p.1-147, Article 147

2022

Volltextzugriff (PDF)

Accuracy of screening strategies for masked hypertension: a large-scale nationwide study based on home blood pressure monitoring

Hypertension research, 2023-03, Vol.46 (3), p.742-750

2023

Volltextzugriff (PDF)

The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives

Frontiers in clinical diabetes and healthcare (online), 2023-09, Vol.4, p.1243530-1243530

2023

Volltextzugriff (PDF)

Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use

Hypertension research, 2019-12, Vol.42 (12), p.1989-1995

2019

Volltextzugriff (PDF)

Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring

Hypertension research, 2019-11, Vol.42 (11), p.1816-1823

2019

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(262)
Mit Volltextzugriff
(239)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(192)
Humans
(154)
Cardiovascular System & Cardiology
(108)
Female
(94)
Male
(94)
Cardiac & Cardiovascular Systems
(85)
Middle Aged
(71)
Peripheral Vascular Disease
(59)
Aged
(56)
Risk Factors
(45)
Adult
(41)
Atherosclerosis
(40)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Blood Pressure
(32)
Myocardial Infarction
(32)
Diabetes
(31)
Endocrinology & Metabolism
(29)
Hypertension
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists

GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data

Effect of aluminum accumulation on bone and cardiovascular risk in the current era

Very low HDL levels: clinical assessment and management

Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study

High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction

Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction

Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk

Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease

Soluble LOX-1 levels during acute coronary syndrome: a potent and multifaceted warning sign for cardiovascular risk

Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial

Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability, and telomere length in healthy octogenarians

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications

Relationship between office isolated systolic or diastolic hypertension and white-coat hypertension across the age spectrum: a home blood pressure study

Cardiac magnetic resonance assessment of right ventricular remodeling after anthracycline therapy

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus

The efficacy and safety of GLP-1 receptor agonists in youth with type 2 diabetes: a meta-analysis

Reference values of office central blood pressure, pulse wave velocity, and augmentation index recorded by means of the Mobil-O-Graph PWA monitor

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial

Accuracy of screening strategies for masked hypertension: a large-scale nationwide study based on home blood pressure monitoring

The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives

Impact of hypertension phenotypes on the office and 24-h pulse wave velocity and augmentation index in individuals with or without antihypertensive medication use

Blood pressure cutoffs for white-coat and masked effects in a large population undergoing home blood pressure monitoring

Suchergebnisse filtern